Name: MERCK & CO. INC. (MRK) Stock
Brand: MERCK & CO. INC.
Rating: 6 (3 reviews)

MRK Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Chartmill

Merck & Co. Inc. (NYSE:MRK) Presents a Compelling Case for Dividend Investors

10 days ago - By: Chartmill

Merck & Co. Inc. (NYSE:MRK) Q3 2025 Earnings Beat Expectations Despite Stock Decline

a day ago - By: Investor's Business Daily - Mentions: REGN AMGN SNY

Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%

a day ago - By: Merck & Co., Inc.

Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial

2 days ago - By: Zacks Investment Research

Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock

2 days ago - By: The Motley Fool - Mentions: GS VZ

3 Dirt Cheap Stocks to Buy With $1,000 Right Now

3 days ago - By: Zacks Investment Research - Mentions: GSK PFE MRNA

Moderna Q3 Earnings Beat, Stock Up on Revised '25 Spending Plans

3 days ago - By: Zacks Investment Research - Mentions: AZN PFE

AZN Q3 Earnings Top Estimates, Sales Rise As Most Key Drugs Outperform

5 days ago - By: The Motley Fool

Why Merck Is Sinking This Week

5 days ago - By: Stocktwits - Mentions: DUHP DWSH

Merck Stock Rises Upon Receipt Of $700M In Funding For Experimental Cancer Drug

5 days ago - By: Zacks Investment Research - Mentions: AMZN MSFT UNH NVDA ...

Stock Market News for Nov 4, 2025

5 days ago - By: Zacks Investment Research

Why Merck (MRK) is a Top Value Stock for the Long-Term

5 days ago - By: Zacks Investment Research - Mentions: GSK PFE MRNA

Should You Buy Moderna Stock Ahead of Q3 Earnings Report?

5 days ago - By: Merck & Co., Inc.

Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT)

5 days ago - By: Merck & Co., Inc.

Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody

6 days ago - By: Merck Sharp & Dohme

Merck Foundation Launches $22 Million Initiative to Improve Cardiovascular Care in the U.S.

10 days ago - By: Benzinga - Mentions: IHE PPH XLV JNJ ...

Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain

10 days ago - By: Zacks Investment Research - Mentions: AZN ANIP CRMD

MRK Beats Q3 Earnings Estimates, Narrows 2025 Sales View, Stock Down

10 days ago - By: Zacks Investment Research

Merck (MRK) Reports Q3 Earnings: What Key Metrics Have to Say

10 days ago - By: Benzinga - Mentions: IR CDP ENTG BUD ...

Earnings Scheduled For October 30, 2025

10 days ago - By: Investor's Business Daily

Dow Jones Stock Merck Tops Expectations, But Gardasil Challenges Remain

10 days ago - By: Merck & Co., Inc.

Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results

10 days ago - By: Bloomberg

Merck Beat Quarterly Sales Expectations Amid Pivot to New Drugs

11 days ago - By: Merck & Co., Inc.

MERCK & CO. INC. (MRK) Stock News